DE10316566A1 - Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren - Google Patents

Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren Download PDF

Info

Publication number
DE10316566A1
DE10316566A1 DE10316566A DE10316566A DE10316566A1 DE 10316566 A1 DE10316566 A1 DE 10316566A1 DE 10316566 A DE10316566 A DE 10316566A DE 10316566 A DE10316566 A DE 10316566A DE 10316566 A1 DE10316566 A1 DE 10316566A1
Authority
DE
Germany
Prior art keywords
therapy
chlorin
polyvinylpyrolidone
agent
photodynamic diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10316566A
Other languages
German (de)
English (en)
Inventor
Peter Petrov
Tatsiana Trukhacheva
Henadz Isakau
Mikhail Haurylau
Mikhail Kaplan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HAEMATO SCIENCE GmbH
HAEMATO-SCIENCE GmbH
Original Assignee
HAEMATO SCIENCE GmbH
HAEMATO-SCIENCE GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAEMATO SCIENCE GmbH, HAEMATO-SCIENCE GmbH filed Critical HAEMATO SCIENCE GmbH
Priority to DE10316566A priority Critical patent/DE10316566A1/de
Priority to PCT/EP2004/003809 priority patent/WO2004089409A2/fr
Priority to EP04726487A priority patent/EP1610821A2/fr
Publication of DE10316566A1 publication Critical patent/DE10316566A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE10316566A 2003-04-10 2003-04-10 Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren Withdrawn DE10316566A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE10316566A DE10316566A1 (de) 2003-04-10 2003-04-10 Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren
PCT/EP2004/003809 WO2004089409A2 (fr) 2003-04-10 2004-04-08 Agent permettant de diagnostiquer et de traiter des tumeurs malignes de maniere photodynamique
EP04726487A EP1610821A2 (fr) 2003-04-10 2004-04-08 Agent permettant de diagnostiquer et de traiter des tumeurs malignes de maniere photodynamique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10316566A DE10316566A1 (de) 2003-04-10 2003-04-10 Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren

Publications (1)

Publication Number Publication Date
DE10316566A1 true DE10316566A1 (de) 2004-10-28

Family

ID=33038992

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10316566A Withdrawn DE10316566A1 (de) 2003-04-10 2003-04-10 Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren

Country Status (3)

Country Link
EP (1) EP1610821A2 (fr)
DE (1) DE10316566A1 (fr)
WO (1) WO2004089409A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008534670A (ja) * 2005-04-07 2008-08-28 フォト・ダイアグノスティック・デバイシィズ・（ピーディーディー）・リミテッド 光増感剤とｍｒｉ増感剤
US8999933B2 (en) * 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885557A (en) * 1996-02-08 1999-03-23 Estee Lauder Inc. Compositions useful in the phototherapeutic treatment of proliferative skin disorders
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
RU2152790C1 (ru) * 1999-05-12 2000-07-20 Мещерякова Аделия Леонидовна Средство для фотодинамической диагностики и терапии онкологических заболеваний
US20040073277A1 (en) * 2002-04-05 2004-04-15 Geronemus Roy G. High fluence rate activation of photosensitizers for dermatological applications

Also Published As

Publication number Publication date
WO2004089409A2 (fr) 2004-10-21
WO2004089409A3 (fr) 2005-01-13
EP1610821A2 (fr) 2006-01-04

Similar Documents

Publication Publication Date Title
DE1793315C2 (fr)
DE69909794T2 (de) Verwendung eines dipeptids für wiederherstellungsprozesse
DE60004348T2 (de) Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate
DE1417343A1 (de) Verfahren zur Herstellung einer antibiotechnischen Zusammensetzung
DE3129750A1 (de) 5'-aminoalkyl-4',4,8-trialkylpsoralene
DD152473A5 (de) Haarwuchsmittel und verfahren zu ihrer herstellung
DE3033895C2 (fr)
EP0245669B1 (fr) Préparation pharmaceutique pour empêcher les dommages aux cellules vivantes par des radicaux libres, respectivement pour augmenter l'efficacité des composés organiques du soufre et procédé pour augmenter la durée de vie d'organes isolés
DE60204067T2 (de) Verwendung von Xanthenon-4-Essigsäure zur Herstellung eines Medikaments für die Behandlung von hyperproliferativer Störungen
DE2900537C2 (fr)
DE10316566A1 (de) Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren
DE2427732A1 (de) Mittel zum anaesthesieren von saeugetieren
DE4315866C1 (de) Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren
EP3237010A1 (fr) Formulation d'hypéricine pour la thérapie photodynamique
DE1620177C3 (de) N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE102004049910A1 (de) Arzneimittel umfassend Chlorin e6, Purpurin 5 und PVP
DE3023396C2 (de) Arzneimittel zur intravenösen Krebstherapie
DE2729903A1 (de) Antithrombosemittel
EP2776067B1 (fr) Composition pour le diagnostic et le traitement photodynamique des tumeurs
DE1617508C3 (de) Antidepressive Mittel
DE3030314A1 (de) Arzneimittel auf sulfonamidbasis
DE1745676B1 (de) Verfahren zur Herstellung resorbierbarer Formstuecke fuer chirurgische Zwecke
DE3203274A1 (de) Vitamin k(pfeil abwaerts)3(pfeil abwaerts)-(gamma)-cyclodextrin-einschlusskomplex, verfahren zu dessen herstellung und diesen einschlusskomplex enthaltende praeparate
AT233166B (de) Verfahren zur Herstellung von Tetracyclin-Antibiotika enthaltenden Zusammensetzungen
DE2417638C3 (de) 2-Methyl-3-carbäthoxy-4-chlor-5hydroxy-6-dimethylaminomethylbenzofuran und dessen pharmakologisch verträgliche Salze sowie Arzneimittel mit einem Gehalt dieser Verbindungen

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee